Paul Tudor Jones's ADMA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 708,089 shares of ADMA Biologics, Inc. (ADMA) worth $6.38 M, representing 0.01% of the portfolio. First purchased in 2020-Q1, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in ADMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 628,583 shares. Largest reduction occurred in Q4 2023, reducing 173,818 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's ADMA Biologics (ADMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADMA Biologics (ADMA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +628,583 | Add 790.61% | 708,089 | $9.01 |
| Q4 2025 | +13,755 | Add 20.92% | 79,506 | $18.24 |
| Q3 2025 | +65,751 | New Buy | 65,751 | $14.66 |
| Q1 2025 | -22,614 | Sold Out | 0 | $0.00 |
| Q4 2024 | +11,869 | Add 110.46% | 22,614 | $17.15 |
| Q3 2024 | -1,377 | Reduce 11.36% | 10,745 | $19.99 |
| Q2 2024 | +12,122 | New Buy | 12,122 | $11.18 |
| Q4 2023 | -173,818 | Sold Out | 0 | $0.00 |
| Q3 2023 | +146,866 | Add 544.92% | 173,818 | $3.58 |
| Q2 2023 | +26,952 | New Buy | 26,952 | $3.69 |
| Q3 2020 | -20,042 | Sold Out | 0 | $0.00 |
| Q2 2020 | -74,503 | Reduce 78.80% | 20,042 | $2.94 |
| Q1 2020 | +94,545 | New Buy | 94,545 | $2.88 |
Paul Tudor Jones's ADMA Biologics Investment FAQs
Paul Tudor Jones first purchased ADMA Biologics, Inc. (ADMA) in Q1 2020, acquiring 94,545 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held ADMA Biologics, Inc. (ADMA) for 13 quarters since Q1 2020.
Paul Tudor Jones's largest addition to ADMA Biologics, Inc. (ADMA) was in Q1 2026, adding 708,089 shares worth $6.38 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 708,089 shares of ADMA Biologics, Inc. (ADMA), valued at approximately $6.38 M.
As of the Q1 2026 filing, ADMA Biologics, Inc. (ADMA) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in ADMA Biologics, Inc. (ADMA) was 708,089 shares, as reported at the end of Q1 2026.